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Abstract
The 2013 Rostock Symposium on Systems Biology and Bioinformatics in Aging Research was again dedicated to
dissecting the aging process using in silico means. A particular focus was on ontologies, because these are a
key technology to systematically integrate heterogeneous information about the aging process. Related topics
were databases and data integration. Other talks tackled modeling issues and applications, the latter including




1 and 2011,2 the Rostock Symposium on Sys-
tems Biology and Bioinformatics in Aging Research
featured talks by researchers from computer science and
engineering and from experimental and clinical research.
This year these talks were accompanied by philosophers
interested in ontologies. Concluding the workshop, an ini-
tiative (http://denigma.de/data/entry/gerontology) to fos-
ter the development of ontology resources for aging research
was begun, with the objective to reuse already existing
ontologies, such as the Gene Ontology (GO), and to con-
ceptualize our understanding of aging to facilitate its dis-
section.
Ontologies and Databases/Data Integration Focus
Aging is often regarded as a complex multifaceted pro-
cess, and well over 300 theories have been proposed to de-
scribe its cause and mechanisms.3 Many more pathways
have been implicated. However, an overarching theoretical
framework for dissecting and understanding what is
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involved in the aging process is lacking. Ontologies can serve
as a crucial instrument to systematically integrate diverse
data and models describing aging in an efficient manner and
thus to enable the creation of a common knowledge base.
Examples of current efforts to bring about such data inte-
gration can be found in the JenAge consortium, where
structured data are integrated with unstructured text with
the help of ontologies (Udo Hahn), The Jackson Laboratory
Nathan Shock Aging Center, where phenotype/pathology
ontologies are used to capture the data deriving from a
mouse aging study using inbred 31 strains, combining his-
topathological and other data with haplotype maps (Paul
Schofield), the Liverpool Institute of Integrative Biology,
where a crowdsourcing effort of ontology construction and
data integration for enabling reasoning has been initiated
(http://denigma.de) (Daniel Wuttke), and the ROSage con-
sortium, where the experimental measurements must be re-
lated to each other, with the goal of inferring attributes and
integrating other (public) datasets from mouse and human
(Georg Fuellen).
Three talks were thus dedicated to ontologies,4,5 moving
from fundamental, theoretical aspects to practical aspects re-
lating to how ontologies should be implemented in such a way
as to aid further research. Barry Smith (Buffalo, New York)
started with a keynote address entitled ‘‘What is Aging?’’,
beginning with an account of the raison d’eˆtre of ontologies,
namely to serve integration of data across diverse clinical and
scientific fields. The idea is that if common terms are used to
annotate or tag heterogeneous data collected by scientists
working in different disciplines or studying different organ-
isms, then these data will be more easily reused for integration
and analysis. To this end, the terms in ontologies need to be
carefully defined, and Smith examined in this light definitions
of terms central to aging research in standard bio-ontologies
such as the GO,6 the Foundational Model of Anatomy (FMA)
ontology,7 and the Plant Ontology (PO).8 GO defines ‘‘aging’’
as: ‘‘A developmental process that is a deterioration and loss of
function over time.’’ In turn, GO defines ‘‘developmental
process’’ as: ‘‘A biological process whose specific outcome is
the progression of an integrated living unit over time from an
initial condition to a later condition.’’ These terms refer im-
plicitly to what, following the FMA, we might call canonical
development and aging—thus to development and aging as
they occur in the normal unfolding of life (as contrasted, for
example, with what happens in cases of developmental delay/
arrest or of premature aging). To address this problem, Smith
proposed an ontology of development stages based on the
ontology of plant structure developmental stages, which forms
a principal branch of the PO. Finally, distinguishing the pro-
cesses of aging from the aging stage in the life of any given
organism allows us also to understand more clearly the rela-
tion between aging and death.
Dietrich Rebholz-Schuhmann (University of Zurich) then
talked on ‘‘Semantic Normalizaton of Phenotypes: State of
the Art and Prospects.’’ Here, patient data take central stage.
Clinical research is increasingly influenced by biomolecular
research, and in the future clinical decisions will include
biomolecular parameters. Standardizing the patient’s phe-
notype is required to link clinical symptoms to molecular
functions, and the integration of data from the bench to the
bedside helps to generate novel hypotheses and may help to
untangle the multi-morbidity of patients. A number of
resources have been produced to represent phenotypes, e.g.,
the Unified Medical Language System (UMLS), which col-
lects input from different terminological authorities around
the world. Increasingly, ontologies are developed that rep-
resent the phenotypes of humans and model organisms. In
the clinical domain, the terminologies are optimized to spe-
cific signs and symptoms in selected European languages. In
the domain of molecular biology and human genetics,
ontologies such as the GO have thus far been used primarily
in studies of genetic disorders and molecular dysfunctions
and to enable comparisons across model organisms. This
means, however, that there is a certain lack of interopera-
bility with the sorts of clinical phenotype representations
contained in the UMLS. Both types of ontology were re-
viewed and evaluated, and judged for their usefulness in
understanding aging processes; in the future it will be im-
portant to bring both worlds together.
Daniel Wuttke (University of Liverpool) and Anton Ka-
luga spoke on the topic of ‘‘Web Intelligence to Solve Aging,’’
introducing the Denigma project (http://denigma.de). De-
nigma is a digital decipher machine, a collaborative platform
for scientists, programmers/engineers, and designers, that
seeks to apply a robust unification procedure to collect, an-
notate, link, and systematize data, resources, and projects
relating to aging research in a way to enable global web-scale
reasoning. It provides a knowledge management system to
support discovery and inference of new knowledge and
novel therapies designed to cure aging. Its key priority is to
combine artificial with natural intelligence, and to this end it
will create aging-specific ontologies that will be compatible
with existing ontologies and use these to alleviate the current
fragmentation of aging research. Thus, there is a strong need
for an integrative effort to consolidate ontology support for
aging research.
A second set of talks described a variety of database ef-
forts, some of which already employ ontologies. These are
based on sophisticated text analytics and database curation.
For example, Udo Hahn (Universita¨t Jena) reported on
‘‘Biomedical Natural Language Processing for Aging Re-
search,’’ describing three services offered by the JenAge lab.
The first provides a semantic document search engine for the
whole of Medline that is adaptable to the needs of the user
through filters enabling focused searching, for example, on
documents relevant to specific aspects of aging research. The
second deals with information extraction from biomedical
documents to empower the automatic synthesis of databases.
Hahn’s group has created a text analytics pipeline that feeds
the JenAge AgeFactDB (http://agefactdb.jenage.de) on a
weekly basis with the latest facts (relating, e.g., to protein–
protein interactions [PPIs] and to aging-relevant genes)
harvested from the most current publications (whereas
manually curated databases typically have an update back-
log extending up to several years). Although this service
takes care of explicit information found in a document, the
third service tries to screen implicit knowledge in texts.
Plausible hypotheses (e.g., potential PPIs, genes tentatively
identified as relevant for aging) are computed on the basis of
evidence detected through reasoning over the documents
analyzed but not explicitly expressed. Hence, this tool may
play a crucial role in the creative processes of shaping,
modifying, and validating scientific hypotheses practiced by
life science colleagues on a daily basis.
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Juergen Suehnel (Leibniz Institute for Age Research, Jena)
announced the first stable release of the JenAge Ageing Factor
database AgeFactDB (http://agefactdb.jenage.de) aimed at
‘‘Data Integration in Age Research.’’ Aging factors are con-
sidered to be genes, chemical compounds, or other factors,
such as dietary restriction, whose action results in a changed
life span or another aging phenotype. Any information re-
lated to the effects of aging factors is called an observation
and is presented on observation pages. To provide concise
access to all available information relating to a particular
gene, corresponding observations are also summarized on
Ageing Factor pages. Initially, aging-related data were taken
primarily from existing databases, namely the GenAge Da-
tabase (http://genomics.senescence.info/genes), the Lifespan
Observations Database (http://lifespandb.sageweb.org), and
the GenDR Database (http://genomics.senescence.info/diet).
Now additional aging-related information has been included
through both manual and semi-automatic extraction from the
scientific literature. On the basis of homology data taken from
the HomoloGene database, AgeFactDB also provides Ob-
servation and Ageing Factor pages for genes that are ho-
mologous to known aging-related genes and thus considered
to be candidate aging-related genes. AgeFactDB offers a va-
riety of search and browse options and also allows down-
loading of aging factor or observation lists in various formats.
Given the complexity of aging, and of biology in general,
an ‘‘Integrative Genomics of Ageing’’ is essential to decipher
the aging process and to help develop life-extending inter-
ventions. Two key questions in biogerontology are: (1) What
are the genetic determinants of human aging in terms of both
differences in longevity between individuals of a given
species and differences in aging between species? (2) What
changes occur in a person from age 30 to age 70 to increase
the chance of dying by roughly 30-fold? Concerning question
(1), the laboratory of Joa˜o Pedro de Magalha˜es (University of
Liverpool) has recently developed the LongevityMap,9 a new
database of human genetic variants associated with longev-
ity (http://genomics.senescence.info/longevity). To help
understand aging changes, his lab also developed the Digital
Ageing Atlas (http://ageing-map.org), a one-stop collection
of human age-related data covering different biological lev-
els (molecular, cellular, physiological, psychological, and
pathological).
Aubrey D.N.J. de Grey presented the efforts of the SENS
Research Foundation on ‘‘Organising Knowledge about
Aging for Efficient Identification of Promising Intervention
Strategies.’’ The complexity of aging presents a daunting
challenge for the design of effective therapies. As our
knowledge of the mechanisms of aging increases, it has
become increasingly clear that a multi-pronged, divide-
and-conquer strategy to attack it will be needed. However,
deciding what set of prongs is likely to work best is excep-
tionally challenging when every therapy manipulating one
part of the system may have side effects affecting others
negatively. A solution may be found more easily by use of a
knowledge base that collects and organizes data in a form
that can show users the predicted knock-on effects of a given
therapy or combination of therapies. Such a system is es-
sentially a curated literature database, storing what indi-
vidual academic and other sources state about the changes
that occur with age in a given species (or organ, or cell type),
the causal relationships between such changes, and the effect
of a given medical (or experimental) intervention on a given
change. Future enhancements may include the ability to
store rates of change, including non-linear ones, and to in-
corporate alternative, mutually contradictory sets of data for
the purpose of identifying experimental avenues to improve
understanding of how aging occurs.
In a panel discussion on ontologies during the workshop,
speakers stressed the need for a formal representation of data
on phenotypes and diseases associated with aging as a critical
step toward the computational analysis of large aging-related
datasets. Such datasets may then be related to each other,
both within and across species, and analyzed computation-
ally, for example, by assessing phenotypic relatedness of
diseases, over-representation of phenotypes involving spe-
cific biological functions, anatomical or cellular locations, in-
volvement of particular pathways, susceptibility to particular
drug treatments, and so on. The cross-species ontology-based
integration of phenotype information was identified already
in the conclusion of our last report as ‘‘the next key step to
achieving data interoperability across resources, inference of
core findings, and translational medicine.’’2 The consensus of
the panel was that existing ontologies need improvement and
extension to be ready to be used in combination with aging-
related data. But as Barry Smith pointed out, the goal cannot
be to add another ontology to the already large number of
existing ontologies listed, for example, in the Bioportal
(http://bioportal.bioontology.org) or in Open Biological and
Biomedical Ontologies (OBO) (www.obofoundry.org) or in
Ontobee (www.ontobee.org). Rather, it is necessary to re-use
as much as possible from existing ontologies and to improve
on these with regard to those terms used in the aging research
community. As a particular challenge, Udo Hahn identified
the degree to which existing ontologies neglect the dimension
of time, with rare exceptions such as the embryonic mouse
ontology eMAP.10,11 During the conference, a group of par-
ticipants started the initiative to develop an ontology for
aging research, called ‘‘GerOntology’’ (GERO) (http://de
nigma.de/data/entry/gerontology), which is designed to
cover aging-related phenomena from the molecular through
phenotypical up to the demographic level via the systematic
re-use of relevant terms from existing ontologies.
Data Integration, Analysis, and Modeling
Moving away from the ontology and database focus, to-
ward integrative bioinformatics analyses, some new tools
were presented at the symposium. In her talk on ‘‘Focus
Networks for the Integration of Large-scale Data,’’ Bianca
Habermann from the MPI for the Biology of Ageing (Co-
logne) introduced algorithms developed in her lab for the
integration and interpretation of large-scale data with the
help of protein interaction networks. The Cytoscape plugins
vIPer (virtual Pathway Explorer), PEANuT (Pathway En-
richment ANalysis Tool), and COMFI (COMplex FInder) are
designed to overlay expression, or other numerical, data on
interaction networks of proteins. They allow constructing
focus networks between two or more nodes that are
weighted according to numerical (e.g., expression) values
that are enriched with pathway and complex information.
With viPEr, the user can explore the neighborhood of a spe-
cific node fruther, looking for paths emanating from a node
that are differentially regulated under a certain experimental
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condition. The power of the software packages in data in-
terpretation was then demonstrated using data from lon-
gevity studies.
Hans Kestler (Ulm University) reported on the ‘‘Cross-
Platform and Inter-Species Integration of Aging Data.’’ He
presented rank aggregation approaches as a means to inde-
pendently combine individual experimental aging data.
Aging experiments can share common differences and con-
served processes, although the experimental conditions may
vary, like different animal models, tissues of interest, or high-
throughput platforms. A higher confidence in the genes that
are involved in aging may be achieved by also comparing
results with other studies related to aging research. This can
be achieved by operating on ranks (and thus being inde-
pendent of effect size) and subsequently combining ranked
lists of genes from single experiments. Instead of just using a
set of genes, rank aggregation can use the different ranks of
genes in each study, to build up a consensus ranking of
differentially expressed genes. The determined consensus
ranking represents a ranking of genes that are common
across the individual experiments. With this approach, new
processes related to aging (e.g., from KEGG pathways) can be
discovered by the combination of different data sources not
found in individual investigations.
For the Rostock ROSAge consortium, Georg Fuellen
(University of Rostock), gave a brief update of their analyses
of ‘‘Mouse Mitochondria and Ageing.’’ The study is now in
its third year, and preliminary data show differences in life
expectancy, in particular under stress conditions, of the
conplastic strains featuring mitochondrial mutations. To
develop and test data analysis tools and methodology, a
similar dataset (The Jackson Laboratory Nathan Shock Aging
Center study from the Mouse Phenome Database; see the
talk by Paul Schofield) was analyzed extensively, with
the discovery of role-changing biomarkers with an anti-
longevity effect in early age groups and a pro-longevity
effect later on. Then, Johannes Wollbold (University of Ro-
stock) talked about ‘‘The Free Radical Theory of Ageing:
Rules, Exceptions, and Counterexamples.’’ Because the clas-
sical free radical theory is seriously challenged, he collected
and ordered existing knowledge focusing on the questions of
reactive oxygen species (ROS) increase, molecular damage,
and effects on life span. He developed a specific method of
knowledge-base construction. Data reported in the literature
or collected within the ROSAge consortium is formalized as
Ripple Down Rules, a structure of general rules and excep-
tions.12 This rule set is further validated and completed by
the attribute exploration algorithm13 of Formal Concept
Analysis: Implicational rules proposed by the algorithm are
accepted or counter-examples are given. Thus, a minimal
rule base is defined systematically; from this base, all im-
plications valid according to the available knowledge can be
derived logically. Hence, queries can be answered regarding
possible, recognized, necessary, and sufficient conditions of
accelerated and retarded aging.
Detailed modeling of aging-related processes was again a
topic at the symposium, concerning epigenetics and cell
proliferation. Specifically, Joerg Galle (University Leipzig)
presented joint work with Jens Przybilla, Thimo Rohlf, and
Markus Loeffler, on ‘‘Understanding Epigenetic Changes in
Ageing Stem Cells—A Computational Model Approach.’’
During aging, a decline in stem cell function is observed in
many tissues. This decline is accompanied by complex
changes of the chromatin structure; among them are changes
in histone modifications and DNA methylation, both of
which affect transcription of a tissue-specific subset of genes.
A mechanistic understanding of these age-associated pro-
cesses, their interrelations, and environmental dependence is
currently lacking. Therefore, a multi-scale computational
model, which combines a model of epigenetic regulation of
transcription with an individual cell-based model of stem cell
populations, was developed. Applying the model, changes
in regulatory states were analyzed, following loss of meth-
ylation of lysine 4 at histone H3 at gene promoters due to
limited inheritance of this mark during replication.
Sascha Scha¨uble and Christoph Kaleta (University Jena)
presented two approaches for the analysis of aging-related
data sets under the title ‘‘Integrative Data Analysis in Age
Research: From Differential Equations to Constraint-Based
Models.’’ In the first approach, a quantitative model of the
transition from proliferating fibroblasts (P) via reversibly cell
cycle–arrested (C) to irreversibly arrested senescent cells (S)
was reconstructed. By applying senescence marker quanti-
fication to this model, it was possible to discriminate be-
tween the considered cellular states. This model allowed
elucidating differences in the stress response of different
fibroblast cell lines. By evaluating marker specificity,
Senescence-associated b-galactosidase (SA-b-Gal) proved a
good quantitative marker for cellular senescence in WI-38
and BJ cells, but less so in MRC-5 cells. The second approach
aimed at an integrative analysis of RNAseq data sets across
several species and several tissues. To this end, a constraint-
based approach that allows mapping of changes in expres-
sion data on a common reference metabolic network was
developed. By comparing changes in gene expression across
several species and tissues, subsystems of metabolism could
be identified that show common as well as differential pat-
terns of regulation during aging across and between tissues.
Experimental and Clinical Contributions
As always, application-focussed talks were important to
connect to ‘‘the real world’’ of aging research and to learn
about the variety of experimental and clinical models and the
types of data gathered. Paul Schofield (University of Cam-
bridge), with colleagues at The Jackson Laboratory ( John
Sundberg) and University of Pittsburgh (Annarose Berndt),
presented ‘‘The Genetic and Histopathologic Basis of Aging
in Inbred Mice,’’ which discussed the genetic dissection of
age-related pathology and life span using inbred strains of
laboratory mice.14 Inbred strains of mice have been used for
many years in the analysis of overall genetic contributions to
longevity, but the age-related accumulation of morbid
changes has generally been documented in F1 (e.g., C57BL/
6N·C3H/HeN] F1) and outbred stocks of mice, making it
difficult to conduct genetic analysis. With the sequencing of
many inbred strains of mice and establishment of high-
density single-nucleotide polymorphism (SNP) maps, it is
now possible to examine traits, such as predisposition to
early development of lymphomas or resistance to degener-
ative changes, in a panel of inbred mice and to map them
rapidly using association analysis. The pathology screen of
The Jackson Laboratory Nathan Shock Aging center study on
31 inbred strains of mice is the largest longitudinal life span
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study conducted on mice. Several association studies show
age-related predisposition to neoplastic and degenerative
disease, and ontologies (see above) are used in the capture
and analysis of pathology data.
Staying with mice as models, Andreas Simm (University
of Halle) then discussed ‘‘Protein Glycation in Biological
Aging: A Double-Edged Sword.’’ Biological aging is in-
duced by the gradual accumulation of cellular and molec-
ular faults. An important cause of faults is intense stress,
like oxidative or glycogenic stress. Whereas high stress in-
duces premature aging, low stress can induce the genetic
repair/defense systems, leading to increased life span. An
example for such a stressor is advanced glycation end
products (AGEs). AGEs can induce inflammation, oxidative
stress, protein dysfunction, and cell death. They are con-
sidered as biomarkers of aging and are associated with
cardiovascular diseases. Besides endogenous formation,
significant amounts of AGEs are taken up with food. Al-
though nutritional AGEs are considered as undesirable,
pro-inflammatory agents, they may also enclose potentially
beneficial anti-oxidants. Mouse cardiac cells were stimu-
lated with bread crust (high AGEs) to analyze signal
transduction pathways as well as gene expression. Ad-
ditionally, mice fed with bread crust containing diet
were analyzed to prove the in vivo relevance for the
heart. In mouse cardiac fibroblasts, bread crust extract in-
duced a moderate elevation of ROS production causing an
activation of p42/p44MAPK, p38MAPK, and nuclear fac-
tor-jB (NF-j]B), followed by increased expression of anti-
oxidative enzymes. Pre-conditioning studies demonstrated
that this was sufficient to protect cardiac fibroblasts and rat
adult cardiac myocytes against severe oxidative stress.
Furthermore, mice fed a bread crust–containing diet ex-
hibited a similarly improved cardiac expression of anti-
oxidative defense genes. Therefore, the consumption of
AGEs can contribute to an improved anti-oxidant status
of the heart, thus exhibiting cardioprotective effects in case
of severe oxidative stress, as in ischemia reperfusion injury.
Also using mice, Melanie Boerries and Hauke Busch
(University of Freiburg) presented an ‘‘ ‘Omics’ View on
Kidney Aging.’’ They performed a transcriptome and me-
thylome analysis of primary glomeruli from young, middle-
aged, and old mice. Glomeruli constitute the main filtration
unit in the kidney. They are partially constituted by podocyte
cells, which are post-mitotic and as such sensitive to aging.15
This leads to a high correlation between the glomerular fil-
tration rate (GFR) and age, hinting at a major involvement of
glomeruli in kidney aging. Pairwise comparison of the glo-
meruli age groups by gene set enrichment analysis showed a
progressive down-regulation of cell division, DNA repair,
and extracellular matrix with age, while various metabolic
processes as well as cytochromes p450s became up-
regulated. Integrating results from previous analyses, target
gene set enrichment, and network analysis, a putative tran-
scription factor network was proposed. Interestingly, many
of the age-related changes could be attributed to the non-
podocyte fraction of glomeruli, reducing the expected func-
tional role of podocytes in kidney aging.
In the final mouse talk, Andreas Hoeflich (FBN Dum-
merstorf, Germany) reported on ‘‘Reproductive Develop-
ment and Aging: A Mouse Model for the Dissection of
Growth, Aging, and Sexual Maturation.’’ Under conditions
of growth inhibition or growth stimulation, an extended or
shortened life span, respectively, has been observed. The
negative correlation between growth and aging, which ex-
clusively has been derived from within-species studies, is not
present on the level of inter-species comparisons because
smaller species normally have shorter life spans than larger
ones. Thus, a direct effect of growth on life span actually is
under intense debate (e.g., Gordon IGF-Conference 2013;
www.grc.org/programs.aspx?year=2013&program= insulin).
Until now, reproductive development was considered as a
potential parameter for the determination of life span, but a
mammalian model to test for the causal interrelationships
between growth, aging, and reproductive dynamics was
lacking. However, by using different insulin-like growth
factor-binding protein-2 (IGFBP-2) transgenic mouse models
over-expressing normal IGFBP-2 or mutated IGFBP-2, it
turned out to be possible to dissect growth from aging, but
not reproductive development from aging. In other words, in
the within-species study reported, there was no support for a
correlation between growth and aging, only between repro-
ductive development and aging. An important future issue
will be related to the question if reproductive development is
a structural determinant of life span or if both reproductive
development and life span are fixed by earlier ontogenetic
development.
Skin aging converges on the dermal stroma consisting
mainly of dermal fibroblasts and surrounding matrix.
Homeostasis of that compartment relies on adaptation and
damage clearance rather than cell turnover. Human dermal
fibroblasts thus present a long-lived cell system prone to
aging-related damage accumulation and adaptation/mala-
daptation. Fritz Boege (University Du¨sseldorf ) reported
‘‘Ingrained Phenotype Changes of Dermal Fibroblasts from
Donors Aged 20–67 Years.’’ This systematic study was re-
stricted to female donors, excluding gender influence.
All primary cells studied were isolated from the same skin
area, minimizing variances of body location and external
milieu. The study focused on alterations conserved in pri-
mary culture at low population doubling, excluding repli-
cative senescence in vitro. Genome-wide array analysis failed
to detect significant age-related changes in gene expression.
Nevertheless, the cells exhibited systematic age-related
alterations of nuclear and mitochondrial function, encom-
passing: (1) Increases in chromosome breakage, base-
line DNA damage response, and up-regulation of non-
homologous end-joining components; (2) decreased
mitochondrial content and respiratory function due to insuf-
ficient activation of mito-biogenesis; and (3) increased pro-
pensity to enter cellular senescence. In summary, in situ aging
of dermal fibroblasts recapitulated some, but not all, features
of nuclear and mitochondrial dysfunction reported from fi-
broblasts subjected to stress-induced or replicative aging in
culture.
Human aging is associated with DNA methylation
(DNAm) changes at specific sites in the genome. These epi-
genetic modifications may be used to track donor age for
forensic analysis or for estimation of biological age.16 In his
talk on ‘‘Age-Associated DNA-Methylation Changes are
Reversed in Pluripotent Stem Cells,’’ Wolfgang Wagner
(RWTH Aachen) reported on such age-related DNAm (AR-
DNAm) changes identified from more than 500 DNAm
profiles from blood. These AR-DNAm changes were further
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validated in independent datasets. He reported how these
modifications, in analogy to senescence-associated DNAm
changes which are acquired during long-term culture in vitro,
are reversed upon reprogramming into induced pluripotent
stem cells (iPSCs).17,18
Eva C. Wo¨nne and Thomas Hiller (Charite´, Berlin) pre-
sented a ‘‘3D Liver Cell Culture Technology for Analyzing
Effects of Reactive Oxygen Species (ROS) and Associated
Cellular Damage on Aging.’’ Their technology is based on a
three-dimensional network of capillaries serving as a de-
centralized, continuous culture medium supply and gas
exchange. In this way, a culture environment allowing for
studies on primary liver cells in a physiological-like envi-
ronment is provided. In cooperation with the group of
Andreas Nu¨ssler (Eberhard-Karls Universita¨t Tu¨bingen),
Reinhard Guthke (Hans-Kno¨ll-Institut Jena), and Dirk Koczan
(BMFZ Rostock), the effect of different ethanol concentrations
on primary rat or human hepatocytes cultured in the system
was analyzed. Typical metabolic liver parameters as well as
glucose and lactate are measured to detect possible effects of
the ethanol exposure. Gene Set Enrichment Analysis (GSEA)
and KEGG pathway mapping are used to characterize bio-
logical categories in the given set of up-reglated and down-
regulated genes in primary liver cells cultured in an in vitro
three-dimensional culture model.
Finally, Anne Meinema and Georges Janssens (University
of Groningen) presented their preliminary results of ‘‘Mole-
cular System-Level Phenotyping to Unravel Causes in Yeast
Ageing,’’ a part of the Systems Biology Centre of Gronin-
gen’s initiative to characterize the aging process in yeast. At
present, numerous genes and cellular mechanisms have been
related to aging. However, the field is far from a compre-
hensive understanding at the molecular level, even in a
simple eukaryote such as Saccharomyces cerevisiae. Yeast cells
age with every new descendent that is formed (replicative
aging). However, due to exponential growth of the yeast
culture, isolation of sufficient aged mother cells for pheno-
typing is difficult. To overcome this, a setup has been created
to immobilize iron bead–labeled yeast cells on a magnetized
column. A constant and steady supply of fresh nutrients en-
sures continued cell division and removal of emerging off-
spring. Aged mother cells and their corresponding offspring
are harvested at 16 different time points during the complete
yeast life span of 72 hr. The amounts are sufficient to map the
full transcriptome reproducibly, as well as the proteome.
Conclusions
The motivation for the ontology focus was described in
part in the conclusions of the last report.2 Because aging
operates on multiple hierarchies of organismal complexity,
its understanding requires glueing together a wide variety of
heterogeneous data sources. For this reason, both the bioin-
formatics as well as the systems biology approaches in the
computational biology of aging would benefit greatly from a
common formal knowledge representation that captures all
the phenomena associated with aging and incorporates rel-
evant datasets or at least provides modal access to those data
in a uniform and computer-understandable format. Such an
ontological framework would enable investigators to take
advantage of the discoveries made in multiple model
systems, commonly used in aging research, as well as data
represented in various formats, from unstructured to highly
structured data sources.
Because such an undertaking cannot be accomplished
solely by a single person nor a single research group, it has to
become a community effort, crossing many disciplines, and
done in a systematic way by involving people from relevant
disciplines including aging researchers, clinicians, bioinfor-
maticians, systems biologists, and knowledge engineers as
well as ontologists, fostering ontologies as common format,
providing a common language.
A major challenge is to design the ontologies used in such
a way that they allow to perform reasoning on scales that
bridge the gap between the genotype and phenotype from
the level of single molecules up to those of the level of
populations for multiple species. The notion of time and
especially lifetime stages has to be captured and encoded
by these ontologies. On the cellular level, the ontological
framework should thus encompass temporal development of
high-throughput data, cellular ultra-structures, and cellular
morphological phenotypes, for example, following the outline
given in reference 19. Inference should be of high quality and
enable well-defined predictions that can be tested with ex-
periments, either in silico, in vitro, or in vivo, and therefore
facilitate the identification of interventions that will help to
decelerate aging and extend health span both theoretically and
practically (project ID 0315581). Finally, funding within the
EU FP7 project MARK-AGE and the COST Action CM1001.
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